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Abstract
Kaposi sarcoma (KS) is a multifocal, vascular lesion of low-grade malignant potential that presents
most frequently in mucocutaneous sites. KS also commonly involves lymph nodes and visceral
organs. This article deals with the manifestation of KS in unusual anatomic regions. Unusual
locations of KS involvement include the musculoskeletal system, central and peripheral nervous
system, larynx, eye, major salivary glands, endocrine organs, heart, thoracic duct, urinary system
and breast. The development of KS within wounds and blood clots is also presented. KS in these
atypical sites may prove difficult to diagnose, resulting in patient mismanagement. Theories to
explain the rarity and development of KS in these unusual sites are discussed.
Background
Kaposi sarcoma (KS) is a vascular lesion of low-grade
malignant potential that is associated with Human Her-
pesvirus-8 (HHV8) infection. KS is a multifocal tumor
that manifests most frequently in mucocutaneous sites,
typically the skin of the lower extremities, face, trunk, gen-
italia and oropharyngeal mucosa (Table 1). KS also com-
monly involves lymph nodes and visceral organs, most
notably the respiratory and gastrointestinal tracts. Pecu-
liar presentations of KS reported in relation to the gas-
trointestinal tract involvement include primary KS of the
appendix [1], isolated rectal KS [2], and KS with
mesenteric localization [3]. Scores of authors have
reported on the occurrence of KS in numerous unusual
sites (i.e. anatomic locations other than the aforemen-
tioned sites). This review discusses the manifestation of
KS in several of these unusual regions of the human body,
and highlights what can be learned from these perceptive
published observations.
Musculoskeletal system
KS involvement of the musculoskeletal system is a rare
occurrence [4]. Nevertheless, around 70 such cases have
been reported. Dr. Moriz Kaposi was the first to document
KS involvement of the skeletal system. He described ulcer-
ating KS lesions on the extremities of his patients that pen-
etrated into underlying bone [5]. Limited early literature,
pre-dating the AIDS epidemic, reported that skeletal
involvement was a frequent (~20%) finding in African
(endemic) KS [6-8]. The largest review to date on KS
involvement of the musculoskeletal system included 66
previously published cases reported from 1925 to 2006
[9]. Only three cases in this review included KS within
skeletal muscle, all AIDS-related KS, that had infiltrated
the gastrocnemius muscle [10], intercostal muscles with
associated rib destruction [11], and the masseter muscle
in association with oral KS [12]. Within the musculoskel-
etal system, osseous KS lesions are more frequently
encountered than KS in skeletal muscle. Involvement of
bone marrow, without causing an osseous lesion, is far
more common in AIDS-related KS [13-16]. In a series of
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tal abnormalities, researchers found that only two indi-
viduals had KS of the bone [17]. Most of the patients in
this series had infections and several had bone lympho-
mas.
The musculoskeletal system has been shown to be
involved by all KS epidemiological forms, including
AIDS-related, Classic, African (endemic), and infre-
quently transplanted-associated KS [9,18-21]. Reports of
African KS bone lesions originated mainly from central
Africa (e.g. Uganda), but also from Northern African
countries (e.g. Algeria, Morocco) and from South Africa.
Despite an extensive literature search, we were able to
identify only a single case of transplanted-associated KS
involving bone. This particular 40 year-old female trans-
plant recipient, who was being treated with cyclosporine,
died 8.3 months after her kidney transplant of dissemi-
nated KS, diagnosed only by post-mortem examination
[22].
African and Classic KS lesions tend to involve the periph-
eral skeleton, whereas AIDS-related KS more commonly
involves the axial skeleton (vertebrae, ribs, sternum, and
pelvis) and/or maxillofacial bones [9,23-32]. KS of the
skull has been noted in the parietal and temporal bones,
paranasal sinus, maxilla, hard palate and mandible. Other
bones reported to be involved by KS include the vertebrae
(T11 to L4), ribs, sternum, pelvis, long bones of the
extremities (humerus, radius, ulna, femur, tibia, fibula),
as well as those of the hands (metacarpals) and feet (talus,
calcaneus, and the 3rd, 4th and 5th metatarsals). Asymmet-
ric bone involvement by KS appears to be the rule. Joint
involvement is unusual, but has been reported [33].
Osseous KS lesions are more likely to be associated with
long-standing and locally aggressive cutaneous African
and Classic KS lesions, or with AIDS-associated mucosal
KS lesions that penetrate underlying bone [9]. Patients
with osseous KS may complain of bone pain with limited
mobility. Serious sequelae have occurred, such as acute
spinal cord compression [34,35]. KS of the jaw bones can
cause pain, headache, increased tooth mobility, paresthe-
sia, or can present with an intraoral tumor mass. Infre-
quently, osseous KS lesions may be asymptomatic and
remain undetected, or may be discovered only inciden-
tally or at autopsy. Pathological fractures in afflicted
patients do not seem to be a problem. KS involvement of
bone without KS disease elsewhere is exceptional [9].
Patients with osseous KS usually have concomitant non-
osseous KS lesions, particularly those with AIDS. Very few
cases, all AIDS patients, have had primary intraosseous KS
[25,36,37]. Most of the cases reported in the literature to
date were due to KS arising in overlying skin or mucosa,
in which KS eroded into underlying bone [4,9]. Those
with AIDS-associated osseous KS often present with a
CD4+ T-cell count of <100 cells/mm3[9]. AIDS-related KS
that involves bone usually portends an unfavorable prog-
nosis [9,38].
Most osseous KS lesions are osteolytic, with cortical and at
times almost complete bone destruction (osteolysis). KS
of the bone does not present well on plain radiographs,
despite their frequent osteolytic nature [38-40]. CT scan
and MRI appear to be superior for the detection of KS
bone lesions [9,11]. Biopsy of a suspected KS lesion is
essential, because other conditions such as bacillary angi-
omatosis can present with similar clinical and radiological
findings [41]. Radiation therapy has provided patients
with prompt relief of bone pain [13,21,31]. Treatment of
osseous KS whether by surgery, chemotherapy and/or
radiation seems to have limited success [1,9]. Neverthe-
less, individual case reports describing improvement of
patients following radiation and/or systemic chemother-
apy have been published [26,36,42]. Patient's response to
therapy requires monitoring radiological changes in addi-
tion to routine clinical observation. With intraosseous KS
involvement, successful management generally requires a
multidisciplinary approach [43].
Nervous system
1. Peripheral nervous system
Peripheral nerve involvement by KS is rare. In a postmor-
tem study of temporal bones obtained from patients with
AIDS, investigators discovered KS in the eighth cranial
nerve of one patient [44]. An autopsy in this individual
revealed concomitant KS of the skin and lungs. In another
study of African KS cases, KS was portrayed growing along
perineural spaces of large nerves [45]. This paper also
described small nerves encased in subcutaneous KS nod-
Table 1: Usual and unusual anatomical locations of Kaposi 
sarcoma
Usual Locations Unusual Locations
• Skin • Bones & skeletal muscles
• Oral mucosa • Peripheral nerves
• Lymph nodes (superficial & deep) • Brain & spinal cord
• Lungs, endobronchial tract, & pleura • Larynx
• Gastrointestinal tract • Eye & ear
• External genitalia • Major salivary glands
• Oropharynx • Adrenal & thyroid gland
• Tonsils • Heart
• Nasal cavity • Thoracic duct
• Liver • Kidney
• Spleen • Ureter & urinary bladder
• Bone marrow • Breast
• Gonads
• Pancreas
• Wounds & blood clotsPage 2 of 9
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system involvement is of a 75-year-old woman who pre-
sented with low back and leg pain, asymmetrical lower leg
weakness, muscle wasting, paresthesiae, and bilateral
lower extremity edema [46]. At autopsy, KS was identified
infiltrating the lumbar spinal cord, sacral plexus, sciatic
and femoral nerves of this patient. In the spinal cord there
was nearby recent microinfarction, and petechial hemor-
rhage was noted. Along involved peripheral nerves there
was associated endoneurial edema and massive destruc-
tion of axons and myelin sheaths. Two lumbar dorsal root
ganglia contained KS tumor in their capsules. Sections
taken from distal popliteal nerves showed wallerian
degeneration. Skeletal muscle from the lower extremities
in this individual revealed neurogenic atrophy.
2. Central nervous system (CNS)
2.1 Brain
Around 15 cases of suspected brain involvement with KS
have been reported [47-58], but in only a few of these
cases did an autopsy actually confirm KS within intracra-
nial lesions [50,52,55]. Human herpes virus-8 (HHV8)
DNA was detected by PCR in one patient's intracranial
lesion [58]. In a review of a transplant tumor registry in
Israel, of 29 donors with CNS tumors 7% were due to KS
[59]. Patients with Classic, African, AIDS-related and
transplant-associated KS epidemiological forms involving
the brain have all been reported. KS has been documented
predominantly in the cerebrum, but has been noted also
in the cerebellum, pons, meninges and dura mater. KS
within the brain appears to almost always occur with gen-
eralized KS disease, including widespread visceral involve-
ment. Symptoms related to brain KS are not well reported.
One patient (16-year-old boy) with transplant-associated
intracranial KS presented with a generalized tonic and
clonic seizure [58]. Another patient with African KS devel-
oped hemiparesis and urinary incontinence due to wide-
spread KS involvement of her skull, vertebrae and brain
[50]. At autopsy, this patient's brain lesions included five
well-delineated nodules of KS, showing considerable
hemorrhage and necrosis. KS tumor cells in these nodules
were reported to be markedly pleomorphic.
A few of the cases reported have been regarded with some
suspicion by others, as the patients in these reports did
not have skin lesions [60]. Based upon available informa-
tion, KS brain lesions have ranged in size from 2 mm to
large (up to 2 cm) destructive deposits. The radiologic
appearance of intracranial KS has only been rarely
described [52,61]. On CT scan, KS appears as homogene-
ous, hyperdense lesions with little surrounding edema
and minimal mass effect. On MRI, brain KS lesions also
appear as a homogeneous mass, of high signal intensity
with a relatively T2 weighted sequence. In one case the CT
scan (without contrast material) was negative, while the
MR image showed an abnormal focus.
2.2 Spinal cord
There have been two cases of KS infiltrating the spinal
cord [34,48]. In one patient presenting acutely with spinal
cord compression, there was concomitant destructive KS
of the thoracic and lumbar vertebrae [34]. In the other
patient with chronic neurological symptoms, KS involved
the lumbar spinal cord [48]. Autopsy in this latter individ-
ual also revealed nearby recent microinfarction and
petechial hemorrhages in the spinal cord.
Larynx
Head and neck involvement of KS is not unusual. How-
ever, laryngeal involvement is somewhat of an infrequent
manifestation. There have been approximately 25
accounts of KS of the larynx [62-73]. Most patients have
had AIDS-related KS, although HIV-negative persons with
laryngeal KS have also been noted [72,74]. Of the AIDS
cases reported, the majority (91%) were males of mean
age 35 years (range 24–56 years), with advanced HIV dis-
ease, that were antiretroviral naïve [73]. This may explain
why many afflicted persons also had oropharyngeal, as
well as cutaneous and visceral KS.
Presenting symptoms may include hoarseness, throat dis-
comfort, urge to cough, aphonia, dysphagia, stridor or
complete airway obstruction. Examination may reveal
laryngeal edema or more likely a purple vascular mass
lesion. The lesion's surface can appear verrucous in
nature, due to deposits of dry secretion [62]. The diagno-
sis can be established by laryngoscopy or radiologic stud-
ies. A CT scan of the larynx may help delineate laryngeal
mass lesions. While a diagnostic biopsy in several patients
was performed without complications, biopsy of such vas-
cular laryngeal lesions has been associated with brisk and
potentially fatal bleeding [65].
Therapeutic options for this scenario include low-dose
local irradiation, intralesional chemotherapy or laser
ablation, and systemic therapy, particularly if there is dis-
seminated KS. For laryngeal KS lesions producing acute or
impending airway obstruction urgent intervention is nec-
essary. However, depending on the location of the KS
lesion, tracheostomy may contribute to mortality as a
result of fatal hemorrhage [66]. Therefore, cricothyrotomy
has been recommended by some authors as an alternative
approach to life-threatening emergencies in this setting.
Eye
Periorbital edema may occur with KS of the face [75,76].
External ocular KS lesions are also not uncommon. KS of
the conjunctiva and ocular adnexa has been reported in
association with Classic and AIDS-related KS [77-87]. Iso-Page 3 of 9
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[88,89]. In a study of 6,552 AIDS patients from Buenos
Aires in Argentina, ocular KS was diagnosed in 17 (0.25%)
individuals [90]. Lesions in this study predominated in
eyelids, most with the inferior eyelid affected. A similar
study from Zaire in Africa (1962 – 1991) reported on 11
patients with ocular adnexal KS, representing an incidence
of 1.25 for 10,000 cases [91]. In this study, 9 of the
patients had AIDS. It has been previously pointed out that
ocular KS may be the first manifestation of HIV infection
[85].
External ocular KS may manifest as a mass lesion or sim-
ply as a subconjunctival hemorrhage. Interestingly,
increased sludging of conjunctival blood-flow has been
shown in patients with KS [92]. Epiphora (overflow of
tears) due to KS of the nasolacrimal duct has been seen
[93]. Far less common, KS may involve the internal struc-
tures of the eye. In one case with widely disseminated KS,
tumor involving the choroid of both eyes was identified at
autopsy [46]. A case of widely disseminated AIDS-associ-
ated KS localized in the patient's orbit has been previously
described [94]. Despite intensive chemotherapy, progres-
sion in this patient was aggressive with a fatal outcome.
While regression of conjunctival KS has been documented
in some cases [95], so to has recurrence following surgical
treatment and cryotherapy of ocular adnexal KS in AIDS
patients [80].
Major salivary glands
KS can involve the parenchyma and/or intraparenchymal
lymph nodes of the major salivary glands [96]. Both the
submandibular and parotid glands have been involved.
The parotid is the only salivary gland with substantial
lymphoid tissue. This explains why most case reports of
KS were of intraparotid lymph nodes, particularly in the
setting of AIDS [97-99]. Excluding intraparotid lymph
node involvement, around 10 cases have been reported in
which KS was identified infiltrating the acinar tissue of
major salivary glands [100-103]. Patients with KS of their
salivary glands have been reported to present clinically for
evaluation primarily because of a 1 cm to 4 cm mass or
swelling of the major salivary gland that was present from
1 to 70 months [103]. Findings of HHV8 DNA in saliva
prompted investigators to study the presence of this virus
in several salivary gland neoplasms [104]. They found that
HHV8 does not appear to infect the salivary gland in HIV-
seronegative patients, nor does it not seem to play a path-




Very few detailed case reports of adrenal KS have been
published, mostly in patients with AIDS [105,106]. Adre-
nal KS has been documented in post-mortem studies in
19% of examined patients with Classic (sporadic), 18%
with African (endemic), and 17% with AIDS-related (epi-
demic) KS [8]. The adrenal cortex appears to be involved
far more frequently than the medulla [60].
2. Thyroid gland
Involvement of the thyroid gland by KS is exceedingly
rare, and presently only 5 cases have been reported
[53,107-111]. In 2 cases the diagnosis was made at
autopsy. In the other patients, the diagnosis was estab-
lished by FNA. Patients have presented with a slowly
enlarging asymptomatic thyroid nodule [111], as well as
hypothyroidism in one case due to actual destruction of
the thyroid gland by KS [108].
3. Pituitary gland
No report of KS involving the pituitary was found. In par-
ticular, KS of the pituitary gland was not identified in a
series of 49 autopsied patients with AIDS in which the
pituitary gland was specifically studied [112].
Heart
Cardiac involvement has been reported in the various epi-
demiologic forms of KS. The results of autopsy studies
conducted from 1959–1986 identified KS of the heart in
18% of African (endemic), 17% in AIDS-related (epi-
demic), and 15% of Classic (sporadic) KS [8]. Cardiac dys-
function directly due to KS involvement has not been
noted [8]. In Classic KS, heart involvement has been
reported to occur more likely in patients without cutane-
ous disease [107,113]. Surprisingly, primary cardiac KS
has been found in a Haitian woman with AIDS [114]. The
epicardium (subepicardial adipose tissue) appears to be
more commonly involved than the myocardium or endo-
cardium [8,115-117].
Thoracic duct
Chylothorax is a known, but rare manifestation of KS
involving the thoracic duct and adjacent mediastinal
structures [118-123]. KS related chylothoraces frequently
develop with concomitant upper airway KS disease [122].
Interestingly, a case of chylous ascites caused by KS has
been previously documented [124]. Although KS-related
chylothorax formation was initially postulated to develop
due to metastatic KS to the thoracic duct [118], more
recent findings suggest that this may arise due to develop-
ment of in-situ KS in this region [123].
Urinary System
Genital KS lesions are common. Infrequently, urethral
meatal lesions may cause outlet obstruction and urinary
retention [125,126]. However, KS of the urinary system
has only been rarely reported, despite the fact that HHV8
is shed in urine from infected patients [127]. There havePage 4 of 9
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130]. Interestingly, all three patients were renal transplant
recipients. In one patient KS involved a transplanted kid-
ney, ureter and urinary bladder [129].
Breast
Since HHV8 can be detected in breast milk [131], it is not
unexpected that KS may arise within mammary tissue. KS
development on lymphedematous arms following radical
mastectomy has been reported in two patients [132,133].
KS within the breast may involve breast parenchyma or
intramammary lymph nodes [134]. There have been three
cases reported of mammary KS [135-137]. Breast involve-
ment has been reported without evidence of KS disease
elsewhere, and also in the setting of disseminated cutane-
ous KS. KS can present as a small deep palpable mass or as
a cutaneous lesion. KS axillary lymphatic involvement in
one HIV infected patient produced lymphatic obstruction,
causing a peau d'orange appearance of the breast [136].
Wounds
Localization of KS to sites of previous iatrogenic trauma
has been documented [138,139], several with underlying
immunosuppression [140]. One publication describes
oral KS arising after minor surgery in a transplant patient
[141]. KS in this particular case developed soon (within 6
days) after the patient's trauma. A similar case of KS occur-
ring de novo in the surgical scar of a heart transplant recip-
ient has been published [142]. A case of primary
intraosseous KS developed in the tibia of an HIV-negative
20-year-old man at the exact same site of a prior traumatic
bone injury and operative scar [20]. Another osseous
lesion in the mandible of a 52-year-old man with AIDS
arose in the area of previously extracted teeth [23]. More-
over, there have been cases noted of KS arising in tissue
grafts [143,144]. Around 10 cases of KS associated with
pemphigus lesions have been described, mainly with
pemphigus vulgaris and less commonly foliaceus and ery-
thematosus variants [145,146]. KS occurring in a der-
matome previously involved by herpes zoster has been
shown [147], as well as primary KS due to prior radiation
[148].
Blood clots
A case of transplant-related KS restricted to the site of a
previous deep venous thrombosis has been documented
[149]. This 72-year-old male patient with a renal trans-
plant had received immunosuppressant drugs including
sirolimus, mycophenolate mofetil, tacrolimus and ster-
oids. His KS developed 11 months after transplantation,
in relation to deep venous thrombosis and withdrawal of
sirolimus due to toxicity. Progressive withdrawal of pred-
nisone was accompanied by full remission of this
patient's KS.
Conclusion
It is clear from the aforementioned review that KS has
been reported in virtually all anatomic sites. KS involve-
ment of other unusual sites not discussed in this chapter
include the gonads (e.g. testis) [150], endometrium [46],
and external auditory meatus [151]. The rarity of KS
reports in uncommon regions may be due be to underre-
porting, asymptomatic lesions, declining number of cur-
rent autopsies being performed, and/or under recognition
of signs by health care providers. Many of these patients
were reported to have AIDS in the pre-HAART era
(<1996), with widely disseminated disease. While KS has
been documented in infants as young as 6-days-old [152],
KS of the placenta does not appear to have yet been
reported.
As a result of HIV, a significant increase in anatomically
disseminated KS cases was evident. The anatomical distri-
bution of KS lesions also changed during the AIDS period.
Soon after the onset of the AIDS epidemic, head and neck
AIDS-related KS became one of the most common mani-
festations of AIDS [153]. In a study involving Tanzanian
children, investigators noted that in approximately 12%
of children KS appeared in anatomical sites that were usu-
ally not involved in cases of the pre-AIDS period, viz. the
eyelid, ear, lip, face and genitalia [154]. Furthermore,
researchers also reported a significant increase in upper
limb cases and a decrease in lower limb and lymph node
involvement [154]. The manifestations of KS have also
changed considerably with the advent of HAART. As a
result of HAART, a smaller proportion of KS patients
appear to present with visceral disease [155]. In particular,
gastrointestinal tract and pulmonary involvement are less
frequent among KS-HAART patients [155]. The frequency
of mucosal and lymph node involvement do not appear
to be appreciably altered by HAART [155].
The occurrence of KS in any of these atypical sites may
prove difficult to diagnose, particularly if patients are
asymptomatic, lesions go unrecognized on routine imag-
ing studies (e.g. osseous KS on plain x-ray films), and/or
clinician's are unwary of their existence [156]. Awareness
that KS can occur in any of these unusual locations may
avoid potential misdiagnosis with serious consequences
(e.g. spinal cord compression) and/or mismanagement
(e.g. biopsy of laryngeal KS with subsequent life-threaten-
ing hemorrhage). Also, the possibility of occult HIV infec-
tion should be entertained in a young person with an
unusual clinical presentation (e.g. subconjunctival hem-
orrhage), as KS may mimic common lesions and represent
the initial presenting sign of AIDS.
In several cases, there was limited available clinical data.
Pathologic verification of a diagnosis of KS by means of
biopsy and/or autopsy was not available in some cases. InPage 5 of 9
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authors noted that histological proof of actual bone
involvement by KS was only obtained in 53% of cases [9].
Very rarely was HHV8 demonstrated within any of these
lesions. Therefore, it is plausible that some published
cases may not truly represent KS. KS involvement of infre-
quent sites may not be considered in the differential diag-
noses. In HIV infected persons, for example, brain lesions
and salivary gland enlargement are frequently identified
and more likely to be attributed to other non-KS causes.
Hence, in the setting of HIV/AIDS, it is important to
always consider KS in the differential diagnosis.
It is interesting to hypothesize why KS is rarely encoun-
tered in the aforementioned anatomic locations. Moreo-
ver, why KS involvement of sites like the bladder and
breast are uncommon when HHV8 is shed in urine and
breast milk, respectively, from infected patients is intrigu-
ing. A urinary protein called ANUP (antineoplastic uri-
nary protein) has certainly been shown to inhibit KS
growth in a murine model [157]. Conversely, investiga-
tors have shown that nerve growth factor, possibly related
to HHV8 infection, may be involved in KS progression
[158]. Moreover, KS cells secrete a neurotrophic growth
factor [159]. One would expect these findings to support
more frequent KS involvement of neural tissue.
It is also unclear if isolated KS lesions in some of these
sites represent primary or disseminated disease. Some
authors have considered the occurrence of KS in unusual
locations to represent metastatic disease [54,160]. Alter-
natively, KS may arise in numerous sites via multicentric
development. It is widely believed that since the eyes and
brain are relatively devoid of lymphatic endothelium,
these organs are unlikely to be sources of primary KS if KS
tumor cells are indeed derived from lymphatic endothe-
lium [160-162]. Direct histological evidence of the devel-
opment of early (in-situ) KS from lymphatic vessels in the
setting of chronic lymphedema has been shown [123].
KS lesions develop as a result of the following combina-
tion of factors: HHV8, altered immunity (immunosup-
pression), and an inflammatory/angiogenic milieu. This
may explain why, in the appropriate clinical setting, KS
develops in traumatized tissue or pemphigus lesions
[145]. Some authors believe that post-traumatic KS
lesions represent the Koebner phenomenon (the appear-
ance of a skin lesion as a result of trauma) [141,147]. The
Koebner phenomenon has been reported by several
authors to develop in Classic, AIDS-related and trans-
plant-associated KS [163,164]. Although still controver-
sial, pemphigus has been associated with HHV8 [165].
Trauma may precipitate inflammatory changes that
recruit HHV8 to the injured site. Finally, specific inflam-
matory cytokines like interleukin-6, shown to be
increased in both serum and blister fluid of pemphigus
patients [166], are essential for KS tumorigenesis.
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